UniDoc Announces Purchase Agreement for AGNES Connect Software from AMD Telemedicine

Wed, 19 Mar 2025 13:00:00 +0000
Press Releases

*Strategic Acquisition to Enhance UniDoc's eHealth Software Capabilities*

*VANCOUVER, BC / ACCESS Newswire / March 19, 2025 / *UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), an innovator in the eHealth sector, is pleased to announce it has entered into a definitive purchase agreement (the "Agreement") for the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD"). This software forms the foundation of UniDoc's previously announced NEIL Connect software platform.

Highlights of proposed acquisition of AGNES Connect:

· Accelerates the expansion and enhancement of UniDoc's NEIL Connect software platform.

· UniDoc gains immediate access to existing AGNES Connect customers and plans continued support and expansion of this client base.

· Strengthens UniDoc's integrated AI-driven telehealth offering with secure data-sharing and EMR integration capabilities.

AGNES Connect, is a secure, encrypted, cloud-based clinical examination platform recognized for its robust telemedicine capabilities. The software enables healthcare providers to capture and securely exchange medical data, documents, and images in real-time alongside high-quality video conferencing. AGNES Connect seamlessly integrates into healthcare facilities' electronic health record (EHR) systems, simplifying clinical workflows and documentation.

Pursuant to the terms of the Agreement effective March 18, 2025, UniDoc has agreed with AMD to acquire the name "AMD Telemedicine" and related goodwill, together with the AGNES Connect software and related intellectual property, trademarks, customer subscriptions and accounts. As consideration, the Company has agreed to pay AMD US$175,000 in cash plus a revenue share. The acquisition remains subject to customary conditions for transactions of this nature including the approval of the Canadian Securities Exchange, if required. The Company expects closing of the acquisition to occur shortly.

UniDoc CEO Antonio Baldassarre notes, "The proposed acquisition of AGNES Connect will strengthen our NEIL Connect platform, and position UniDoc to deliver a more comprehensive and seamless eHealth solution. This integration will immediately enhance our software capabilities and provide direct access to an established customer network, presenting new opportunities to generate sustainable revenue and enhance shareholder value."

UniDoc, upon closing of the acquisition, intends to continue to support and expand the existing AGNES Connect customer base, delivering improved software updates and enhanced customer service. The NEIL Connect platform is currently integrated with partners Carefluence and DocBox software, and leverages advanced artificial intelligence (AI) to facilitate more accurate intake/triage (MediOrbis) and more efficient patient monitoring (DocBox), further supporting UniDoc's mission to bridge gaps in healthcare accessibility and quality.

Ensuring strict adherence to healthcare data protection standards, UniDoc's NEIL Connect platform that supports compliance with the Health Insurance Portability and Accountability Act (HIPAA). Patient information is securely managed, encrypted, and integrated with hospital and clinical databases, aligning with industry-leading security practices and standards.

UniDoc is committed to further enhancing its telehealth solutions through continuous innovation and strategic growth initiatives, and anticipates leveraging AGNES Connect software once acquired to increase operational efficiencies and drive greater shareholder value.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

*About UniDoc Health Corp*. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

*For further information, please contact:*

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com

*Forward-Looking Statements*

This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the highlights of the proposed acquisition of AGNES Connect, the expansion and enhancement of UniDoc's NEIL Connect software platform; closing of the acquisition and the timing thereof; the acquisition of the AGNES Connect software and its impact on the business of the Company; the Company continuing to support and expand the existing AGNES Connect customer base, and delivering improved software updates and enhanced customer service; the acquisition of the AGNES Connect customer base and accounts, the possible expansion of customer accounts; the Company enhancing shareholder value, generating sustainable growth, increasing operational efficiencies and bridging gaps in healthcare accessibility and quality; and the benefits the NEIL Connect software will add to the Company's products and that it will allow doctors to improve the accuracy of their diagnoses.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 31, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.

Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

*The CSE does not accept responsibility for the adequacy or accuracy of this release.*

*SOURCE: *UniDoc Health Corp.
View the original press release on ACCESS Newswire